sodium salicylate has been researched along with Atherosclerotic Parkinsonism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nehru, B; Thakur, P | 1 |
| Aomine, M; Obata, T; Yamanaka, Y | 1 |
2 other study(ies) available for sodium salicylate and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Catalase; Cytokines; Dopamine; Homovanillic Acid; Inflammation; Male; Monoamine Oxidase; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rotenone; Sodium Salicylate | 2013 |
Potassium chloride depolarization enhances MPP+-induced hydroxyl radical generation in the rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cyclooxygenase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Herbicides; Hydroxyl Radical; Iron; Male; Membrane Potentials; Microdialysis; Parkinson Disease, Secondary; Potassium Chloride; Rats; Rats, Wistar; Sodium Salicylate | 2000 |